The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Revvity posts higher Q4 earnings, lifts 2026 outlook as diagnostics strength offsets margin pressure
Zydus receives FDA’s tentative approval for Dapagliflozin Tablets
Lupin launches Topiramate ER capsules in US
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes